Imagen de Portada
Código QR

The Impact of Independent Chemotherapy Prescribing by Advanced Practice Providers on Patient Safety and Clinician Satisfaction.

BACKGROUND: Literature on advanced practice providers (APPs) prescribing chemotherapy independently, without physician cosignature, is limited. OBJECTIVES: This project assessed safety and provider satisfaction for an existing independent APP chemotherapy prescribing privilege at a National Cancer I...

Descripción completa

Publicado en:Clinical Journal of Oncology Nursing Vol. 28; no. 4; pp. 397 - 406
Autores principales: LeStrange, Nicole, Walton, AnnMarie, Watson, Joni L., Sklarin, Nancy T., Thompson, Julie A., Affronti, Mary Lou
Formato: questionnaire/scale research tables/charts Journal Article
Publicado: Oncology Nursing Society Aug2024
Acceso en línea:Ver este registro en EBSCOhost
Sumario:BACKGROUND: Literature on advanced practice providers (APPs) prescribing chemotherapy independently, without physician cosignature, is limited. OBJECTIVES: This project assessed safety and provider satisfaction for an existing independent APP chemotherapy prescribing privilege at a National Cancer Institute-designated comprehensive cancer center. METHODS: Rate of Reporting to Improve Safety and Quality events associated with APPs with independent chemotherapy prescribing privileges was compared to that of physicians during a threeyear period. Satisfaction of APPs with independent chemotherapy prescribing privileges was evaluated. FINDINGS: The odds of a reported event were higher for physicians than for APPs. APP survey responses were positive for readiness, confidence, and satisfaction with independent chemotherapy prescribing privilege.